Co-Trimoxazole (sulfamethoxazole trimethoprim): Reviews and patient testimonials

Co-Trimoxazole 40 mg/200 mg per 5 ml Paediatric Suspension

Co-Trimoxazole Paediatric Suspension is indicated in children aged 12 years and under (infants (>6 weeks to <2 years old) and children (>2 to <12 years old) for the treatment of the following infections when owing to sensitive organisms:

• Treatment and prevention of Pneumocystis jirovecii pneumonitis (PJP).

• Treatment and prophylaxis of toxoplasmosis.

• Treatment of nocardiosis.

The following infections may be treated with Co-Trimoxazole where there is bacterial evidence of sensitivity to Co-Trimoxazole and good reason to prefer the combination of antibiotics in Co-Trimoxazole to a single antibiotic:

• Acute uncomplicated urinary tract infection.

• Acute otitis media.

• Acute exacerbation of chronic bronchitis.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Co-Trimoxazole 80 mg/400 mg per 5 ml Adult Suspension

Co-Trimoxazole Adult Suspension is indicated in children (>12 to <18 years old) and adults (>18 years old) for the treatment of the following infections when owing to sensitive organisms:

• Treatment and prevention of Pneumocystis jirovecii. pneumonitis (PJP)

• Treatment and prophylaxis of toxoplasmosis

• Treatment of nocardiosis

The following infections may be treated with Co-Trimoxazole where there is bacterial evidence of sensitivity to Co-Trimoxazole and good reason to prefer the combination of antibiotics in Co-Trimoxazole to a single antibiotic:

• Acute uncomplicated urinary tract infections

• Acute otitis media

• Acute exacerbation of chronic bronchitis

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Co-Trimoxazole 80 mg/400 mg Tablets

Co-Trimoxazole tablets are indicated in children (>12 to <18 years old) and adults (>18 years old) for the treatment of the following infections when owing to sensitive organisms:

• Treatment and prevention of Pneumocystis jirovecii pneumonitis or “PJP”.

• Treatment and prophylaxis of toxoplasmosis.

• Treatment of nocardiosis.

The following infections may be treated with Co-Trimoxazole where there is bacterial evidence of sensitivity to Co-Trimoxazole and good reason to prefer the combination of antibiotics in Co-Trimoxazole to a single antibiotic:

• Acute uncomplicated urinary tract infection.

• Acute otitis media.

• Acute exacerbation of chronic bronchitis.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Co-Trimoxazole 800mg/160mg Forte Tablets

Co-Trimoxazole Forte tablets are indicated in children (>12 to <18 years old) and adults (>18 years old) for the treatment of the following infections when owing to sensitive organisms.

• Treatment and prevention of Pneumocystis jirovecii pneumonitis or “PJP”.

• Treatment and prophylaxis of toxoplasmosis.

• Treatment of nocardiosis.

The following infections may be treated with Co-Trimoxazole where there is bacterial evidence of sensitivity to Co-Trimoxazole and good reason to prefer the combination of antibiotics in Co-Trimoxazole to a single antibiotic:

• Acute uncomplicated urinary tract infection.

• Acute otitis media.

• Acute exacerbation of chronic bronchitis.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Co-Trimoxazole for infusion 16 mg/ 80mg per ml

Co-Trimoxazole for Infusion is indicated in children aged 12 years and under (>6 weeks to <12 years old); children over 12 years old (>12 to < 18 years old) and adults (>18 years old) for the treatment of the following infections when owing to sensitive organisms:

• Acute uncomplicated urinary tract infection: It is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single effective antibacterial agent rather than a combination such as Co-Trimoxazole for Infusion.

• Treatment and prevention of Pneumocystis jirovecii pneumonitis or “PJP”.

• Treatment and prophylaxis of toxoplasmosis.

• Treatment of nocardiosis.

• In general, the indications for the use of Co-Trimoxazole for Infusion are the same as those for oral presentations.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Co-Trimoxazole Tablets 80/400mg

Co-trimoxazole is indicated in adults and children over 12 years.

Co-trimoxazole tablets are indicated for the treatment of the following infections when owing to sensitive organisms:

- Treatment and prevention of Pneumocystis jiroveci pneumonitis.

- Treatment and prophylaxis of toxoplasmosis

- Treatment of nocardiosis.

The following infections may be treated with co-trimoxazole where there is bacterial evidence of sensitivity to co-trimoxazole and good reason to prefer the combination of antibiotics in co-trimoxazole to a single antibiotic:

- Acute uncomplicated urinary tract infection

- Acute otitis media

- Acute exacerbation of chronic bronchitis

Consideration should be given to official guidance on the appropriate use of antibacterial agents.